# Rebranding Summary: OMOP Cohort Builder â†’ Vantage RWE

## âœ… Rebranding Complete

The application has been successfully rebranded from "OMOP Cohort Builder" to **"Vantage RWE"** (Real-World Evidence).

### New Brand Identity

**Name**: Vantage RWE  
**Tagline**: "Commercial Intelligence from Real-World Evidence"  
**Version**: 2.0.0  
**Target Audience**: Pharmaceutical commercial teams

---

## ğŸ“ What Changed

### Documentation (9 files)
- âœ… `README.md` - Main introduction and feature overview
- âœ… `ARCHITECTURE.md` - Technical architecture
- âœ… `QUICKSTART.md` - Getting started guide
- âœ… `SETUP_GUIDE.md` - Installation instructions
- âœ… `PROJECT_SUMMARY.md` - Project overview
- âœ… `EXAMPLE_COHORTS.md` - Example queries
- âœ… `PRESCRIBER_ANALYTICS.md` - Prescriber analytics docs
- âœ… `MARKET_SHARE_ANALYTICS.md` - Market share docs
- âœ… `GENIE_INTEGRATION.md` - Databricks Genie integration

### Frontend (3 files)
- âœ… `frontend/package.json` - Package name changed to `vantage-rwe-ui`, version 2.0.0
- âœ… `frontend/public/index.html` - Page title and meta description
- âœ… `frontend/src/App.tsx` - Header title and subtitle

### Backend (2 files)
- âœ… `backend/app/main.py` - API title, description, version, logging messages
- âœ… `backend/app/api/routes.py` - Health check endpoint

---

## ğŸ¯ New Positioning

### Before (Cohort Builder Focus)
- Cohort building tool
- OMOP data access
- Basic analytics

### After (Commercial Intelligence Platform)
- **Patient Cohort Analytics**: Build and analyze patient populations
- **Prescriber Analytics**: Target HCPs, analyze prescribing patterns
- **Market Share Intelligence**: Track competitive position and trends

---

## ğŸš€ What's Next

### To See the Changes:

1. **View in browser** (after restarting):
   ```bash
   # Backend
   cd backend
   uvicorn app.main:app --reload
   
   # Frontend
   cd frontend
   npm start
   ```
   
2. **Check the new branding**:
   - Browser tab title: "Vantage RWE"
   - Header: "ğŸ“Š Vantage RWE"
   - Subtitle: "Commercial Intelligence from Real-World Evidence"
   - API docs at http://localhost:8000/docs

### Current Branch Status
You're on: `feature/market-share-analysis`

This branch now includes:
- âœ… Original cohort builder
- âœ… Prescriber analytics
- âœ… Market share analytics
- âœ… **New Vantage RWE branding**

---

## ğŸ”„ Applying to Other Branches

If you want to apply the rebranding to other branches:

### Option 1: Merge to main (recommended)
```bash
git checkout main
git merge feature/market-share-analysis
```
This brings all features + rebranding to main.

### Option 2: Cherry-pick just the rebranding
```bash
git checkout feature/prescriber-analytics
git cherry-pick 1f0c1a7  # The rebranding commit
```
This applies just the rebranding to another branch.

---

## ğŸ“‹ Files Summary

**Total files changed**: 14

| Category | Files Changed |
|----------|---------------|
| Documentation | 9 |
| Frontend | 3 |
| Backend | 2 |

**Lines changed**: 69 insertions, 33 deletions

---

## ğŸ¨ Brand Guidelines

### Primary Name
**Vantage RWE** (capitalize both words)

### Tagline
**Commercial Intelligence from Real-World Evidence**

### Use Cases
- For pharmaceutical commercial teams
- Brand managers, sales operations, medical affairs
- Real-world evidence generation
- Competitive intelligence

### Key Differentiators
1. Built on OMOP standard (data quality)
2. Databricks-powered (scalability)
3. Three modules (cohorts, prescribers, market share)
4. AI-powered queries (GenAI integration)

---

## âœ… Validation Checklist

- [x] All documentation updated
- [x] Frontend branding updated
- [x] Backend API titles updated
- [x] Version bumped to 2.0.0
- [x] Git commit created
- [x] No code functionality broken (only names changed)

---

**Rebranding completed**: December 11, 2024  
**Commit**: `1f0c1a7` - "rebrand: Rename application to Vantage RWE"  
**Branch**: `feature/market-share-analysis`

